PURE Bioscience, Inc.
PURE
$0.0688
$0.013825.09%
| 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | 10/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -15.55% | 4.58% | 23.95% | 14.02% | 16.73% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -15.55% | 4.58% | 23.95% | 14.02% | 16.73% |
| Cost of Revenue | -21.60% | -10.49% | -3.46% | 0.88% | 8.60% |
| Gross Profit | -10.47% | 18.64% | 57.22% | 27.50% | 24.57% |
| SG&A Expenses | -10.00% | -7.46% | -3.98% | -3.56% | 1.23% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -11.62% | -7.47% | -3.47% | -3.05% | 1.80% |
| Operating Income | 9.13% | 13.70% | 15.65% | 11.42% | 5.84% |
| Income Before Tax | 10.78% | 15.43% | 12.88% | 9.91% | -0.41% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 10.78% | 15.43% | 12.88% | 9.91% | -0.41% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 10.78% | 15.43% | 12.88% | 9.91% | -0.41% |
| EBIT | 9.13% | 13.70% | 15.65% | 11.42% | 5.84% |
| EBITDA | 10.22% | 15.04% | 15.54% | 10.66% | 4.35% |
| EPS Basic | 10.81% | 15.45% | 17.88% | 18.81% | 14.40% |
| Normalized Basic EPS | 4.23% | 9.80% | 17.41% | 18.78% | 20.25% |
| EPS Diluted | 10.81% | 15.45% | 17.88% | 18.81% | 14.40% |
| Normalized Diluted EPS | 4.23% | 9.80% | 17.41% | 18.78% | 20.25% |
| Average Basic Shares Outstanding | 0.29% | 0.41% | 4.91% | 10.89% | 17.62% |
| Average Diluted Shares Outstanding | 0.29% | 0.41% | 4.91% | 10.89% | 17.62% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
